An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Clinical trial NCT01129024 · TERMINATED

Trial details

NCT number: NCT01129024
Sponsor: Shionogi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2010-04-29
Primary completion: 2011-06-30
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.